Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyendocrinopathies, Autoimmune
|
21 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1 | 2009 | 2009 | ||||||
Giant Cell Arteritis
|
78 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Multiple Sclerosis
|
1022 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.710 | 1.000 | 2 | 2011 | 2011 | |||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Immune System Diseases
|
116 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Adult type dermatomyositis
|
31 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Dermatomyositis
|
34 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Lupus Erythematosus
|
44 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Lupus Erythematosus, Discoid
|
46 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Lupus Vulgaris
|
44 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Polymyositis
|
22 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Mucocutaneous Lymph Node Syndrome
|
195 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.820 | 1.000 | 4 | 2012 | 2016 | |||||
Primary Sjögren's syndrome
|
42 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Encephalitis, St. Louis
|
34 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Myositis
|
43 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Autoimmune Diseases
|
428 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.730 | 1.000 | 4 | 2011 | 2017 | |||||
Rheumatoid Arthritis
|
2387 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.830 | 1.000 | 4 | 2009 | 2017 | |||||
Lupus Erythematosus, Systemic
|
1172 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.870 | 1.000 | 13 | 2009 | 2019 | |||||
Systemic Scleroderma
|
287 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.820 | 1.000 | 4 | 2010 | 2019 | |||||
Autoimmune thyroid disease (AITD)
|
54 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Graves Disease
|
352 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Hashimoto Disease
|
131 | 0.683 | 0.480 | 8 | 11486464 | upstream gene variant | C/T | snv | 0.25 | 0.010 | 1.000 | 1 | 2019 | 2019 |